Markowitz O - Search Results

1

Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.

Feldman SR, Matheson R, Bruce S, Grande K, Markowitz O, Kempers S, Brundage T, Wyres M; U0267-301 & 302 Study Investigators. Feldman SR, et al. Among authors: markowitz o. Am J Clin Dermatol. 2012 Aug 1;13(4):261-71. doi: 10.2165/11630710-000000000-00000. Am J Clin Dermatol. 2012. PMID: 22587791 Clinical Trial.

2

A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.

Jorizzo JL, Markowitz O, Lebwohl MG, Bourcier M, Kulp J, Meng TC, Levy S. Jorizzo JL, et al. Among authors: markowitz o. J Drugs Dermatol. 2010 Sep;9(9):1101-8. J Drugs Dermatol. 2010. PMID: 20865842 Clinical Trial.

3

Noninvasive Long-term Monitoring of Actinic Keratosis and Field Cancerization Following Treatment with Ingenol Mebutate Gel 0.015.

Markowitz O, Wang K, Levine A, Schwartz M, Minhas S, Feldman E, Siegel DM. Markowitz O, et al. J Clin Aesthet Dermatol. 2017 Oct;10(10):28-33. Epub 2017 Oct 1. J Clin Aesthet Dermatol. 2017. PMID: 29344318 Free PMC article.

4

Transforming the treatment of psoriasis to the 21st century: Detecting subclinical therapeutic response to secukinumab using optical coherence tomography as a prognostic indicator.

Felice S, Bressler MY, Karim R, Markowitz O. Felice S, et al. Among authors: markowitz o. Lasers Surg Med. 2022 Aug;54(6):825-834. doi: 10.1002/lsm.23551. Epub 2022 May 21. Lasers Surg Med. 2022. PMID: 35598099 Clinical Trial.

5

Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.

Emer JJ, Stevenson ML, Markowitz O. Emer JJ, et al. Among authors: markowitz o. J Drugs Dermatol. 2011 Jul;10(7):795-8. J Drugs Dermatol. 2011. PMID: 21720663

6

Trends in the treatment and detection of skin cancer.

Emer J, Markowitz O. Emer J, et al. Among authors: markowitz o. J Drugs Dermatol. 2011 Jan;10(1):16-8. J Drugs Dermatol. 2011. PMID: 21197515 Review. No abstract available.

7

Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy.

Markowitz O, Schwartz M, Feldman E, Bienenfeld A, Bieber AK, Ellis J, Alapati U, Lebwohl M, Siegel DM. Markowitz O, et al. J Clin Aesthet Dermatol. 2015 Oct;8(10):14-20. J Clin Aesthet Dermatol. 2015. PMID: 26557214 Free PMC article.

8

Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%- Treated Patients.

Markowitz O, Schwartz M, Feldman E, Bieber A, Bienenfeld A, Nandanan N, Siegel DM. Markowitz O, et al. J Clin Aesthet Dermatol. 2016 May;9(5):18-25. Epub 2016 May 1. J Clin Aesthet Dermatol. 2016. PMID: 27386042 Free PMC article.

9

The Use of Noninvasive Optical Coherence Tomography to Monitor the Treatment Progress of Vismodegib and Imiquimod 5% Cream in a Transplant Patient with Advanced Basal Cell Carcinoma of the Nose.

Markowitz O, Schwartz M. Markowitz O, et al. J Clin Aesthet Dermatol. 2016 Aug;9(8):37-41. Epub 2016 Aug 1. J Clin Aesthet Dermatol. 2016. PMID: 27672417 Free PMC article.

10

Commentary on the diagnostic utility of non-invasive imaging devices for field cancerization.

Schwartz M, Siegel DM, Markowitz O. Schwartz M, et al. Among authors: markowitz o. Exp Dermatol. 2016 Nov;25(11):855-856. doi: 10.1111/exd.13103. Exp Dermatol. 2016. PMID: 27248504 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters